MR Solutions introduces 9.4T preclinical MRI imaging solution to cardiovascular sector
MR Solutions’ new 9.4 tesla cryogen free preclinical scanners created great interest from cardiologists at the 20th Annual Scientific Sessions of the Society for Cardiovascular Magnetic Resonance (SCMR). As well as being extremely powerful this new scanner can be multi-modality, incorporating PET and/or SPECT capabilities. MR Solutions’ helium free scanners offer a compact scanner with a small stray field at a very competitive price.
SCMR has worldwide attendance amongst top healthcare professionals who are committed to cardiovascular development and their clinical application. In attendance were cardiologists, radiologists, physicists and technologists.
Both of MR Solutions’ range of preclinical scanners, the Flexiscan and Powerscan were on display. The scanners can incorporate integrated multi-modality options such as PET or SPECT. The Flexiscan system requires no specialist knowledge and can be operated simply by running pre-defined settings. There is no need to materially alter the parameters of the machine.
Dr David Taylor, CEO of MR Solutions commented: “At the SCMR we displayed our latest scanner ranges up to 9.4T which offer multi-modality scanning (including PET or SPECT) and better performance, all at a very competitive cost. This can significantly improve cardiovascular research.”
MR Solutions, which is based in Guildford, UK, is the world’s largest independent developer and manufacturer of preclinical MRI technology and remains the only company to deliver a commercial cryogen free 3T to 9.4T range of preclinical bench top MRI scanners.
To provide the SPECT images, MR Solutions has devised a system where the four gamma camera heads and focusing collimator can be easily clipped on to the front of the bore of the MRI scanner to provide state of the art 3D SPECT images. The SPECT images can be registered with the MRI images providing anatomical-functional combined capability. The SPECT gamma camera can also be used independently.
The PET capability is provided by solid state detectors which are incorporated in the bore of the MRI scanner. The scanner combines the exquisite structural and functional characterisation of tissue provided by MRI with the extreme sensitivity of PET imaging for metabolism and tracking of uniquely labelled cell types or cell receptors. This is particularly useful in oncology, cardiology, and neurology research.
MR Solutions’ range of cryogen free, Benchtop, 3T to 9.4T MRI scanners with 17, 24 and 31 cm bores has become a complete game changer in the field of preclinical scanning. The technology not only provides superior soft tissue contrast and high spatial resolution, a vastly reduced stray magnetic field and all the benefits that brings but also allows the magnetic field strength to be easily varied.
MR Solutions, a winner of the prestigious Queen’s Award for Enterprise 2016 for innovation in the UK, has over 30 years’ experience and in excess of 1000 installations across the world. This includes sales of their MRI spectrometers. Its scanners are renowned for their excellence in terms of superior soft tissue contrast and molecular imaging ability.
MR Solutions has its global headquarters at Ashbourne House, The Guildway, Old Portsmouth Road, Guildford, Surrey GU3 1LR; tel: + 44 1483 532146; firstname.lastname@example.org; www.mrsolutions.com.